StockStorm.ai

Solventum Corporation

SOLV Stock News

Latest SOLV news

Solventum: Divestiture Unlocking Upside In A Spinoff Revaluation Play

Seeking Alpha · Fri, 18 Sep 2026 07:41:59 -0400

Solventum trades at a significant discount to medical technology peers, with a forward P/E of ~13x and suppressed EV/EBITDA multiples. Management is executing a portfolio optimization, including a potential spin-off of the Health Information Systems segment to unlock value and reduce debt. Raised 2026 EPS guidance to $7.10-$7.20 and operating margins to 22.2%-22.7%, signaling margin expansion and improved free cash flow allocation.

Why Solventum (SOLV) is a Top Stock for the Long-Term

Zacks Investment Research · Tue, 15 Sep 2026 10:30:54 -0400

Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.

Market information is provided for research and visualization and is not investment advice.